Wired reporter Sarah Zhang writes about a new proposal from Prof. Andrew Lo to use Wall Street to help lower health care costs. Zhang explains that Lo’s proposal would “theoretically make cures available to more patients, incentivizing the drug industry to make those instead of mitigators.”
In an article for The New York Times, Austin Frakt speaks with Prof. Benjamin Roin about how to encourage drug companies to undertake studies examining whether medications may have multiple uses. Roin suggests that to make such studies feasible, there could be a “universal electronic prescribing system that tracks prescriptions and conditions for which they’re intended.”
In an interview with the BBC, Prof. Heidi Williams argues that there should be more incentives for developing cancer prevention techniques and treatments for early-stage cancers. "If you look at drugs that get approved by the FDA, they all tend to be for very late stage cancer patients,” says Williams.